scholarly journals Complex karyotype with cryptic FUS gene rearrangement and deletion of NR3C1 and VPREB1 genes in childhood B‑cell acute lymphoblastic leukemia: A case report

2020 ◽  
Author(s):  
Moneeb Othman ◽  
Marina Đurišić ◽  
Gordana Samardzija ◽  
Dragana Vujić ◽  
Nina Lakic ◽  
...  
Keyword(s):  
Case Report ◽  
Acute Lymphoblastic Leukemia ◽  
B Cell ◽  
Gene Rearrangement ◽  
Lymphoblastic Leukemia ◽  
Complex Karyotype ◽  
Cell Acute Lymphoblastic Leukemia

scholarly journals Precursor B-cell acute lymphoblastic leukemia presenting as obstructive jaundice: a case report

2011 ◽  
Vol 5 (1) ◽  
Author(s):  
Muhammad N Siddique ◽  
Muhammad Popalzai ◽  
Nelly Aoun ◽  
Rabih Maroun ◽  
Michael Awasum ◽  
...  
Keyword(s):  
Case Report ◽  
Acute Lymphoblastic Leukemia ◽  
Obstructive Jaundice ◽  
B Cell ◽  
Lymphoblastic Leukemia ◽  
Cell Acute Lymphoblastic Leukemia

scholarly journals COVID-19, Acute Lymphoblastic Leukemia, and Down Syndrome: A Short Review and a Case Report

2021 ◽  
pp. 1031-1039
Author(s):  
Ahmed Arafat ◽  
Dinara Sadykova ◽  
Ayrat Ziatdinov ◽  
Svetlana Senek ◽  
Natalya Samoilova ◽  
...  
Keyword(s):  
Down Syndrome ◽  
Case Report ◽  
Acute Lymphoblastic Leukemia ◽  
B Cell ◽  
Treatment Regimen ◽  
Lymphoblastic Leukemia ◽  
Short Review ◽  
Morbidity And Mortality ◽  
Minimal Data ◽  
Cell Acute Lymphoblastic Leukemia

SARS-CoV-2 which causes COVID-19 has been a great challenge to treat and deal with; despite strict measures that had been implemented by governments and organizations, worrying rates of morbidity and mortality are still being reported. Although available data have expressed that moderate or even mild forms of the disease are expected amongst most pediatrics cases, minimal data are available on the prognosis and the disease’s complications on the immunocompromised, especially oncology patients. We report a case of relapsed precursor B-cell acute lymphoblastic leukemia of a child with Down syndrome and COVID-19 and outline the treatment regimen that we used.

scholarly journals BCR-ABL1 gene rearrangement as a subclonal change in ETV6-RUNX1–positive B-cell acute lymphoblastic leukemia

2016 ◽  
Vol 1 (2) ◽  
pp. 132-138 ◽  
Author(s):  
Karen A. Dun ◽  
Rob Vanhaeften ◽  
Tracey J. Batt ◽  
Louise A. Riley ◽  
Giuseppe Diano ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
Tyrosine Kinase ◽  
B Cell ◽  
Tyrosine Kinase Inhibitors ◽  
Gene Rearrangement ◽  
Kinase Inhibitors ◽  
Lymphoblastic Leukemia ◽  
Rare Occurrence ◽  
Key Points ◽  
Cell Acute Lymphoblastic Leukemia

Key Points BCR-ABL1 rearrangement as a subclonal change in ETV6-RUNX1–positive B-ALL is a rare occurrence not previously reported. The prognosis of this rare subclonal change has not been determined, yet inclusion of tyrosine kinase inhibitors in treatment is ubiquitous.

scholarly journals A novel IGH@ gene rearrangement associated with CDKN2A/B deletion in young adult B-cell acute lymphoblastic leukemia

2016 ◽  
Vol 11 (3) ◽  
pp. 2117-2122 ◽  
Author(s):  
MONEEB A.K. OTHMAN ◽  
BEATA GRYGALEWICZ ◽  
BARBARA PIENKOWSKA-GRELA ◽  
JOLANTA RYGIER ◽  
ANNA EJDUK ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
Young Adult ◽  
B Cell ◽  
Gene Rearrangement ◽  
Lymphoblastic Leukemia ◽  
Igh Gene Rearrangement ◽  
Cell Acute Lymphoblastic Leukemia
Sign in / Sign up

Export Citation Format

Share Document